IL154238A0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
IL154238A0
IL154238A0 IL15423801A IL15423801A IL154238A0 IL 154238 A0 IL154238 A0 IL 154238A0 IL 15423801 A IL15423801 A IL 15423801A IL 15423801 A IL15423801 A IL 15423801A IL 154238 A0 IL154238 A0 IL 154238A0
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IL15423801A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL154238A0 publication Critical patent/IL154238A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15423801A 2000-09-11 2001-09-10 Pharmaceutical composition IL154238A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23165500P 2000-09-11 2000-09-11
US23226100P 2000-09-14 2000-09-14
PCT/EP2001/010448 WO2002020090A2 (en) 2000-09-11 2001-09-10 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
IL154238A0 true IL154238A0 (en) 2003-09-17

Family

ID=26925315

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15423801A IL154238A0 (en) 2000-09-11 2001-09-10 Pharmaceutical composition
IL154238A IL154238A (en) 2000-09-11 2003-01-30 Use of 5 - Methyl - 2 - ('2 - Chloro -' 6 - Fluoroanilino) Phenylacetic acid or its common pharmaceutical salt for the manufacture of a remedy for disorder related to cyclooxygenase - 2 and packaging for a drug containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL154238A IL154238A (en) 2000-09-11 2003-01-30 Use of 5 - Methyl - 2 - ('2 - Chloro -' 6 - Fluoroanilino) Phenylacetic acid or its common pharmaceutical salt for the manufacture of a remedy for disorder related to cyclooxygenase - 2 and packaging for a drug containing them

Country Status (28)

Country Link
US (2) US20020061932A1 (de)
EP (1) EP1331972B1 (de)
JP (2) JP2004527458A (de)
KR (1) KR20030036730A (de)
CN (1) CN100490797C (de)
AR (1) AR030630A1 (de)
AT (1) ATE366128T1 (de)
AU (2) AU2002213900C1 (de)
BR (1) BR0113809A (de)
CA (1) CA2416771C (de)
CY (1) CY1107729T1 (de)
CZ (1) CZ2003673A3 (de)
DE (1) DE60129238T2 (de)
DK (1) DK1331972T3 (de)
ES (1) ES2290181T3 (de)
HU (1) HUP0301128A3 (de)
IL (2) IL154238A0 (de)
MX (1) MXPA03002105A (de)
MY (1) MY126117A (de)
NO (1) NO20031095D0 (de)
NZ (1) NZ524785A (de)
PE (1) PE20020351A1 (de)
PL (1) PL359721A1 (de)
PT (1) PT1331972E (de)
RU (1) RU2316324C2 (de)
SI (1) SI1331972T1 (de)
SK (1) SK2902003A3 (de)
WO (1) WO2002020090A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition
GB0201520D0 (en) * 2002-01-23 2002-03-13 Novartis Ag Pharmaceutical uses
PL370907A1 (en) * 2002-03-07 2005-05-30 Novartis Ag Pharmaceutical compositions
JP2006501161A (ja) 2002-06-11 2006-01-12 ニトロメッド インク． ニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物ならびに使用方法
PE20040844A1 (es) 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
TWI327913B (en) * 2003-03-12 2010-08-01 Novartis Ag Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid
US20050131028A1 (en) * 2003-09-11 2005-06-16 Pharmacia Corporation Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
FR2898492B1 (fr) * 2006-03-15 2008-06-06 Pierre Fabre Medicament Sa Comprimes orodispersibles de domperidone
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
WO2008086537A2 (en) * 2007-01-11 2008-07-17 Analog Devices, Inc. Aluminum based bonding of semiconductor wafers
US20110144206A1 (en) * 2008-08-22 2011-06-16 Steven Lewitzky Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity
WO2010056741A2 (en) 2008-11-12 2010-05-20 Auspex Pharmaceuticals, Inc. Phenylacetic acid inhibitors of cyclooxygenase
CN103773596B (zh) * 2013-12-31 2016-05-18 上海复力生物医药科技有限公司 磷虾油的制备方法
CN111278433A (zh) 2017-09-26 2020-06-12 特沙诺有限公司 尼拉帕尼制剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2163111C (en) * 1993-06-08 2010-10-26 Peter Heinrich Stahl Process for the preparation of an oral solid dosage form containing diclofenac
JPH11512754A (ja) * 1996-05-17 1999-11-02 メルク エンド カンパニー インコーポレーテッド シクロオキシゲナーゼ―２媒介疾患の一日一回治療用組成物
CO4960662A1 (es) * 1997-08-28 2000-09-25 Novartis Ag Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
US20030114527A1 (en) * 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition

Also Published As

Publication number Publication date
DE60129238T2 (de) 2008-03-06
EP1331972A2 (de) 2003-08-06
SK2902003A3 (en) 2003-10-07
AU2002213900C1 (en) 2006-07-27
CY1107729T1 (el) 2013-04-18
MY126117A (en) 2006-09-29
RU2316324C2 (ru) 2008-02-10
CA2416771A1 (en) 2002-03-14
WO2002020090A2 (en) 2002-03-14
JP2004527458A (ja) 2004-09-09
AU2002213900B2 (en) 2006-02-16
PE20020351A1 (es) 2002-06-14
NO20031095L (no) 2003-03-10
CN100490797C (zh) 2009-05-27
PL359721A1 (en) 2004-09-06
NZ524785A (en) 2005-10-28
JP2011144194A (ja) 2011-07-28
MXPA03002105A (es) 2003-06-19
DK1331972T3 (da) 2007-11-05
WO2002020090A9 (en) 2003-10-30
ES2290181T3 (es) 2008-02-16
AR030630A1 (es) 2003-08-27
HUP0301128A3 (en) 2005-04-28
AU1390002A (en) 2002-03-22
EP1331972B1 (de) 2007-07-04
US20020061932A1 (en) 2002-05-23
CA2416771C (en) 2010-11-02
PT1331972E (pt) 2007-10-16
WO2002020090A3 (en) 2003-05-30
BR0113809A (pt) 2003-07-29
DE60129238D1 (de) 2007-08-16
CN1455691A (zh) 2003-11-12
CZ2003673A3 (cs) 2003-06-18
ATE366128T1 (de) 2007-07-15
HUP0301128A2 (hu) 2003-10-28
US20040186179A1 (en) 2004-09-23
IL154238A (en) 2008-11-26
SI1331972T1 (sl) 2007-12-31
NO20031095D0 (no) 2003-03-10
KR20030036730A (ko) 2003-05-09

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
IL152659A0 (en) Pharmaceutical composition
HK1075889A1 (en) Pharmaceutical composition
GB2358583B (en) Pharmaceutical compositions
HUP0204555A3 (en) Pharmaceutical composition
HUP0300582A3 (en) Pharmaceutical compositions
AU6219601A (en) Pharmaceutical compositions
GB0009584D0 (en) Pharmaceutical compositions
AU8576801A (en) Pharmaceutical compositions
HUP0400553A3 (en) Pharmaceutical compositions
IL154238A0 (en) Pharmaceutical composition
GB0008485D0 (en) Pharmaceutical compositions
GB0009613D0 (en) Pharmaceutical compositions
GB0005382D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0002691D0 (en) Pharmaceutical composition
GB0026716D0 (en) Pharmaceutical composition
GB0006301D0 (en) Pharmaceutical composition
GB0016684D0 (en) Pharmaceutical composition
GB0019599D0 (en) Pharmaceutical composition
GB0027375D0 (en) Pharmaceutical composition
GB0008872D0 (en) Pharmaceutical compositions
GB0000062D0 (en) Pharmaceutical compositions
GB0001337D0 (en) Pharmaceutical compositions
GB0003929D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed